ROR1 expression correlated with poor clinical outcome in human ovarian cancer - Wikidata - wikimedia - TriplyDB

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

http://www.wikidata.org/entity/Q33942010

about

Wnt5a Signaling in Cancer Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1 Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma Wnt5a Signaling in Normal and Cancer Stem Cells ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.Molecularly Targeted Therapy of Human Hepatocellular Carcinoma Xenografts with Radio-iodinated Anti-VEGFR2 Murine-Human Chimeric Fab High Rab27A expression indicates favorable prognosis in CRC.β-arrestin1 over-expression is associated with an unfavorable prognosis in lung adenocarcinomas and correlated with vascular endothelial growth factor.Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer.ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia.Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer.RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.Hi-C as a tool for precise detection and characterisation of chromosomal rearrangements and copy number variation in human tumours A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway.ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K/Akt pathway.Receptor tyrosine kinases in carcinogenesis.Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors.Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.Backbone and side-chain chemical shift assignments of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1).Anti-ROR1 scFv-EndoG as a Novel Anti-Cancer Therapeutic Drug Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis.

P2860

Q26738408-32E8B435-C990-4A84-A557-2DA47E8CBF11 Q26795679-09494D00-EA1A-4499-996F-CA554F1CDBFC Q28547292-CCF650BF-671B-4344-847D-6991EF47EFE8 Q33604792-70071BBF-09EC-4521-85BF-F500845A1F86 Q33779292-D4F7DE91-014E-4F9F-89F7-1D8EE9DAF96F Q34448718-1B673F58-7F79-416F-B547-D9FADF3B0F2B Q35662815-FD36A0FF-CB5D-4D8A-90FC-1195DB2FCC3E Q35736686-1E32ACC1-2F8B-4AFB-9942-327573F55457 Q35741012-22555320-3A17-413B-B1CE-69039845CBA7 Q35852265-405F09DE-716A-4F43-B2A0-81B9899EB18A Q36545609-94A544FF-6096-437C-97B8-A9C0E4DC1C96 Q37096241-BEE7520F-0F8D-4939-9281-EE7494540913 Q37405620-4325AD82-F664-469C-8151-5D77153F1A11 Q37528063-08514961-3BAE-4E63-9B11-00AC86371766 Q37723027-5B314D30-EECC-4C1D-8539-60F48ED971BF Q38432883-D06A173E-B319-4962-A3D4-B192243E0F47 Q38706431-996BCF27-5A49-4887-96FB-6523FC54D8BE Q38724665-0E84F429-6D09-4D7E-B67D-B42D63E5077A Q38824230-CBE48563-011D-4F7E-A07B-590FDDB68F87 Q39024002-15D77044-6A7A-4667-9400-4B8A6571BBB3 Q39182547-373FBA84-1CBF-4E86-9090-2D9E4678CBB1 Q41252003-A2445BF0-9E11-4C1B-A2BE-9DF78A61D662 Q47137229-D53F846D-F1D9-4716-AEF5-41956C17281F Q48124146-12E8BE1C-BC5C-4C51-A983-D3EC2F8F4148 Q48291380-88BB35CD-50A9-416F-93DF-80F47FFB22EC Q49648716-40E02C04-F899-4036-BD50-D7DB8E810218 Q49658859-01B668A6-EA92-4F90-A3B2-45AEF4374101

P2860

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

http://www.wikidata.org/entity/Q33942010

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

@ast

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

@en

type

label

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

@ast

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

@en

prefLabel

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

@ast

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

@en

P1433

Q33942010-166F625E-C979-4E54-90A8-2A24D0FBA760

P1476

Q33942010-E1A2C8B8-2208-42BF-B541-69D1933EF612

P2093

Q33942010-14DD620B-DD04-48D6-90C6-4BF161CAD9C6

Q33942010-17A60F8E-CEFF-4C8B-935A-5899F04E1C7C

Q33942010-2D37B036-3233-4ECB-8E34-8D47EDDF1FB1

Q33942010-313B110D-926C-4D34-A52E-DADD2CBBE4B3

Q33942010-3844FEEA-D9EA-4A75-A8C8-31982CE758FC

Q33942010-3E0C7FCC-C993-4DD2-AF2E-2DE20821E1CE

Q33942010-65E05C94-C42D-4403-BD5D-E1593AEAB4C1

Q33942010-777DBE91-35D3-4833-91CD-0B4EE6EF7038

Q33942010-B8BB1306-B35B-4438-95DF-C957F9D2B9E6

Q33942010-C09CAF76-E698-449A-98A4-669BD0B2368D

P2860

Q33942010-1158DE00-7A54-4243-AE57-E58D658EC17A

Q33942010-1AC435F3-4279-45A0-B991-DA4A76F8B9E3

Q33942010-1F01B26B-7BD5-4CF5-A64E-4469E4AA0988

Q33942010-20FA3EE1-B2C0-411E-8E40-0B1DD84AE98E

Q33942010-22165BE0-9C24-4E2B-A824-80D7B9B536EB

Q33942010-22C659AB-D4AC-4203-AF5C-B7F4D1886BBD

Q33942010-297932FD-07EA-44CC-86C7-3851632DD489

Q33942010-2BC97D9B-46AA-40D6-81EF-07DCC07B8AC4

Q33942010-30012276-63C0-4ACB-AF8A-0015F10215EF

Q33942010-31492EFE-9969-449B-9838-70C0AC2D1146

P2888

Q33942010-4A64846D-C4BF-4392-B75A-E82BA5D7F864

P304

Q33942010-FCBBA1EF-8A7D-4800-BA07-D8C58910E6E6

P31

Q33942010-A52D3E3A-3B73-491F-85F7-2C25DE233D21

P356

Q33942010-2AE0E52C-49A3-45B1-929A-F202F76A073E

P407

Q33942010-CC2A1693-76E8-41B0-B5DE-35F5BEB55474

P478

Q33942010-167BA77C-726F-4FDD-A111-AA80E78D9DC0

P577

Q33942010-503B9DD3-E8A0-4D72-87EE-A0C6EB8635FF

P5875

Q33942010-86FC9130-474A-4707-89C3-2D4332E7F870

P6179

Q33942010-7F624FD6-A64A-420C-B6E2-F74C5F1C8B9F

P698

Q33942010-E6A82D74-AC2A-4FDF-95AC-0325DAA06583

P921

Q33942010-34824C96-AA9D-4C90-9407-0AC74CFA1787

Q33942010-B3F059CC-920E-4C86-9125-7871E12D7A33

P932

Q33942010-C35554C2-0C47-4223-A5A6-C761592C7DB7

P356

P1433

Scientific Reports

P1476

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

@en

P2093

Chunping Ye

http://www.w3.org/2001/XMLSchema#string

Dawei Zhang

http://www.w3.org/2001/XMLSchema#string

Dazhen Yang

http://www.w3.org/2001/XMLSchema#string

Fengshan Li

http://www.w3.org/2001/XMLSchema#string

Huilin Zhang

http://www.w3.org/2001/XMLSchema#string

Jin Zhu

http://www.w3.org/2001/XMLSchema#string

Jinrong Qiu

http://www.w3.org/2001/XMLSchema#string

Lin Xiong

http://www.w3.org/2001/XMLSchema#string

Lingjuan Gao

http://www.w3.org/2001/XMLSchema#string

Ning Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

Global cancer statistics

NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma

A human Fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo.

ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth.

Mechanisms of resistance to cisplatin.

Selection and characterization of human anti-MAGE-A1 scFv and immunotoxin.

Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells

Generation and characterization of a novel recombinant antibody against LMP1-TES1 of Epstein-Barr virus isolated by phage display.

Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis

P2888

P304

5811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP05811

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264204559

http://www.w3.org/2001/XMLSchema#string

P6179

1053704512

http://www.w3.org/2001/XMLSchema#string

P698

25056203

http://www.w3.org/2001/XMLSchema#string

P921

maternal health

P932

4108928

http://www.w3.org/2001/XMLSchema#string